Landos Biopharma Inc reports results for the quarter ended in March - Earnings Summary

Landos Biopharma

17/05/2021 14:28

* Landos Biopharma Inc  LABP.OQ  reported a quarterly adjusted
loss of 38 cents​​ per share for the quarter ended in March. The
mean expectation of four analysts for the quarter was for a loss
of 37 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Landos Biopharma Inc's reported EPS for the quarter was a loss
of 38 cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Landos Biopharma Inc shares had risen by 21.0% this quarter.
* The company reported a quarterly loss of $9.82 million.
* Wall Street's median 12-month price target for Landos
Biopharma Inc is $32.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 17 at 01:28 p.m. GMT.
​All figures in US dollars